FDA Import Refusal 799-9703977-1/71/1 — Bajaj Formulations

Bajaj Formulations — FEI 3013854037

The FDA refused shipment 799-9703977-1/71/1 from Bajaj Formulations (United Kingdom) on Mar 5, 2024. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charges: 118,3280,75 This firm has 2 other import refusals on record.

Refusal Details

Date
Mar 5, 2024
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
62GCA18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
Charges
118,3280,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.